1-[(1Z)-{[(2-chlorophenyl)methyl]sulfanyl}(methylimino)methyl]pyrazolidin-3-one hydrochloride

Catalog No.: 
ACGLTT783
CAS No.: 
317377-37-0
Molecular Formula: 
C12H15Cl2N3OS
Molecular Weight: 
320.24
1-[(1Z)-{[(2-chlorophenyl)methyl]sulfanyl}(methylimino)methyl]pyrazolidin-3-one hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg90%$102.00InquiryInquiry
1g90%$325.00InquiryInquiry
5g90%$1609.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-[(1Z)-{[(2-chlorophenyl)methyl]sulfanyl}(methylimino)methyl]pyrazolidin-3-one hydrochloride
IUPAC Name2-chlorobenzyl (Z)-N-methyl-3-oxopyrazolidine-1-carbimidothioate hydrochloride
Molecular FormulaC12H15Cl2N3OS
Molecular Weight320.24
SMILESC/N=C(\SCC1=CC=CC=C1Cl)N1CCC(=O)N1.Cl
InChI KeyXEWXZIKRXTXXOC-CTMPBGLUSA-N
Synonym1-[[(2-CHLOROBENZYL)SULFANYL](METHYLIMINO)METHYL]-3-OXOTETRAHYDRO-1H-PYRAZOL-1-IUM CHLORIDE;1-[(1Z)-{[(2-chlorophenyl)methyl]sulfanyl}(methylimino)methyl]pyrazolidin-3-one hydrochloride
CAS No.317377-37-0

Synthetic Route by SureRoute

1. ACGLTT783 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGLTT783 route product structure diagram
    ACGLTT783317377-37-0
Inquiry

2. ACGLTT783 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGLTT783 route product structure diagram
    ACGLTT783317377-37-0
Inquiry

3. ACGLTT783 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGLTT783 route product structure diagram
    ACGLTT783317377-37-0
Inquiry

Comments (0)